Advertisement

Pathology of Lung Rejection: Cellular and Humoral Mediated

  • Anja C. Roden
  • Henry D. Tazelaar
Chapter

Abstract

Acute rejection is an important risk factor for bronchiolitis obliterans syndrome, the clinical manifestation of chronic airway rejection in lung allograft recipients. Patients with acute rejection might be asymptomatic or present with symptoms that are not specific and can be also seen in other conditions. Clinical tests such as pulmonary function tests and imaging studies among others usually are abnormal; however, their results are also not specific for acute rejection. Histopathologic features of acute rejection in adequate samples of transbronchial lung biopsy of the lung allograft are currently the gold standard to assess for acute rejection in lung transplant recipients. Acute alloreactive injury can affect both the vasculature and the airways. Currently, the guidelines of the 2007 International Society of Heart and Lung Transplantation consensus conference are recommended for the histopathologic assessment of rejection. There are no specific morphologic features recognized to diagnose antibody-mediated rejection (AMR) in lung allografts. Therefore, the diagnosis of AMR currently requires a “triple test” including clinical features, serologic evidence of donor-specific antibodies, and pathologic findings supportive of AMR. Complement 4d deposition is used to support a diagnosis of AMR in many solid organ transplants; however, its significance for the diagnosis of AMR in lung allografts is not entirely clear. This chapter discusses the currently recommended guidelines for the assessment of cellular rejection of lung allografts and summarizes our knowledge about morphologic features and immunophenotypic tests that might help in the diagnosis of AMR.

Keywords

Antibody-mediated rejection Humoral rejection Cellular rejection Lung Lymphocytic bronchiolitis 

References

  1. 1.
    Martinu T, Chen DF, Palmer SM. Acute rejection and humoral sensitization in lung transplant recipients. Proc Am Thorac Soc. 2009;6:54–65.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Haque MA, Mizobuchi T, Yasufuku K, Fujisawa T, Brutkiewicz RR, Zheng Y, Woods K, Smith GN, Cummings OW, Heidler KM, et al. Evidence for immune responses to a self-antigen in lung transplantation: role of type V collagen-specific T cells in the pathogenesis of lung allograft rejection. J Immunol. 2002;169:1542–9.CrossRefPubMedGoogle Scholar
  3. 3.
    Yusen RD, Edwards LB, Kucheryavaya AY, Benden C, Dipchand AI, Goldfarb SB, Levvey BJ, Lund LH, Meiser B, Rossano JW, Stehlik J. The Registry of the International Society for Heart and Lung Transplantation: thirty-second official adult lung and heart-lung transplantation report—2015; focus theme: early graft failure. J Heart Lung Transplant. 2015;34:1264–77.CrossRefPubMedGoogle Scholar
  4. 4.
    Martinu T, Pavlisko EN, Chen DF, Palmer SM. Acute allograft rejection: cellular and humoral processes. Clin Chest Med. 2011;32:295–310.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Glanville AR, Aboyoun CL, Havryk A, Plit M, Rainer S, Malouf MA. Severity of lymphocytic bronchiolitis predicts long-term outcome after lung transplantation. Am J Respir Crit Care Med. 2008;177:1033–40.CrossRefPubMedGoogle Scholar
  6. 6.
    Verleden SE, Ruttens D, Vandermeulen E, Vaneylen A, Dupont LJ, Van Raemdonck DE, Verleden GM, Vanaudenaerde BM, Vos R. Bronchiolitis obliterans syndrome and restrictive allograft syndrome: do risk factors differ? Transplantation. 2013;95:1167–72.CrossRefPubMedGoogle Scholar
  7. 7.
    Schulman LL, Weinberg AD, McGregor C, Galantowicz ME, Suciu-Foca NM, Itescu S. Mismatches at the HLA-dr and HLA-b loci are risk factors for acute rejection after lung transplantation. Am J Respir Crit Care Med. 1998;157:1833–7.CrossRefPubMedGoogle Scholar
  8. 8.
    Quantz MA, Bennett LE, Meyer DM, Novick RJ. Does human leukocyte antigen matching influence the outcome of lung transplantation? An analysis of 3,549 lung transplantations. J Heart Lung Transplant. 2000;19:473–9.CrossRefPubMedGoogle Scholar
  9. 9.
    Wisser W, Wekerle T, Zlabinger G, Senbaclavaci O, Zuckermann A, Klepetko W, Wolner E. Influence of human leukocyte antigen matching on long-term outcome after lung transplantation. J Heart Lung Transplant. 1996;15:1209–16.PubMedGoogle Scholar
  10. 10.
    Christie JD, Edwards LB, Kucheryavaya AY, Aurora P, Dobbels F, Kirk R, Rahmel AO, Stehlik J, Hertz MI. The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult lung and heart-lung transplant report—2010. J Heart Lung Transplant. 2010;29:1104–18.CrossRefPubMedGoogle Scholar
  11. 11.
    Mangi AA, Mason DP, Nowicki ER, Batizy LH, Murthy SC, Pidwell DJ, Avery RK, McCurry KR, Pettersson GB, Blackstone EH. Predictors of acute rejection after lung transplantation. Ann Thorac Surg. 2011;91:1754–62.CrossRefPubMedGoogle Scholar
  12. 12.
    Zheng HX, Burckart GJ, McCurry K, Webber S, Ristich J, Iacono A, Dauber J, McDade K, Grgurich W, Zaldonis D, et al. Interleukin-10 production genotype protects against acute persistent rejection after lung transplantation. J Heart Lung Transplant. 2004;23:541–6.CrossRefPubMedGoogle Scholar
  13. 13.
    Zheng HX, Zeevi A, McCurry K, Schuetz E, Webber S, Ristich J, Zhang J, Iacono A, Dauber J, McDade K, et al. The impact of pharmacogenomic factors on acute persistent rejection in adult lung transplant patients. Transpl Immunol. 2005;14:37–42.CrossRefPubMedGoogle Scholar
  14. 14.
    Ibrahim JE, Sweet SC, Flippin M, Dent C, Mendelhoff E, Huddleston CB, Trinkhaus K, Canter CE. Rejection is reduced in thoracic organ recipients when transplanted in the first year of life. J Heart Lung Transplant. 2002;21:311–8.CrossRefPubMedGoogle Scholar
  15. 15.
    Scott JP, Whitehead B, de Leval M, Helms P, Smyth RL, Higenbottam TW, Wallwork J. Paediatric incidence of acute rejection and obliterative bronchiolitis: a comparison with adults. Transpl Int. 1994;7:S404–6.CrossRefPubMedGoogle Scholar
  16. 16.
    Yusen RD, Christie JD, Edwards LB, Kucheryavaya AY, Benden C, Dipchand AI, Dobbels F, Kirk R, Lund LH, Rahmel AO, Stehlik J. The Registry of the International Society for Heart and Lung Transplantation: thirtieth adult lung and heart-lung transplant report—2013; focus theme: age. J Heart Lung Transplant. 2013;32:965–78.CrossRefGoogle Scholar
  17. 17.
    De Vito Dabbs A, Hoffman LA, Iacono AT, Zullo TG, McCurry KR, Dauber JH. Are symptom reports useful for differentiating between acute rejection and pulmonary infection after lung transplantation? Heart Lung. 2004;33:372–80.CrossRefPubMedGoogle Scholar
  18. 18.
    Christie JD, Edwards LB, Kucheryavaya AY, Benden C, Dipchand AI, Dobbels F, Kirk R, Rahmel AO, Stehlik J, Hertz MI. The Registry of the International Society for Heart and Lung Transplantation: 29th adult lung and heart-lung transplant report-2012. J Heart Lung Transplant. 2012;31:1073–86.CrossRefPubMedGoogle Scholar
  19. 19.
    Lowery EM, Bemiss B, Cascino T, Durazo-Arvizu RA, Forsythe SM, Alex C, Laghi F, Love RB, Camacho P. Low vitamin D levels are associated with increased rejection and infections after lung transplantation. J Heart Lung Transplant. 2012;31:700–7.CrossRefPubMedGoogle Scholar
  20. 20.
    Kumar D, Erdman D, Keshavjee S, Peret T, Tellier R, Hadjiliadis D, Johnson G, Ayers M, Siegal D, Humar A. Clinical impact of community-acquired respiratory viruses on bronchiolitis obliterans after lung transplant. Am J Transplant. 2005;5:2031–6.CrossRefPubMedGoogle Scholar
  21. 21.
    Vilchez RA, Dauber J, McCurry K, Iacono A, Kusne S. Parainfluenza virus infection in adult lung transplant recipients: an emergent clinical syndrome with implications on allograft function. Am J Transplant. 2003;3:116–20.CrossRefPubMedGoogle Scholar
  22. 22.
    Garantziotis S, Howell DN, McAdams HP, Davis RD, Henshaw NG, Palmer SM. Influenza pneumonia in lung transplant recipients: clinical features and association with bronchiolitis obliterans syndrome. Chest. 2001;119:1277–80.CrossRefPubMedGoogle Scholar
  23. 23.
    Glanville AR, Gencay M, Tamm M, Chhajed P, Plit M, Hopkins P, Aboyoun C, Roth M, Malouf M. Chlamydia pneumoniae infection after lung transplantation. J Heart Lung Transplant. 2005;24:131–6.CrossRefPubMedGoogle Scholar
  24. 24.
    Sharples LD, McNeil K, Stewart S, Wallwork J. Risk factors for bronchiolitis obliterans: a systematic review of recent publications. J Heart Lung Transplant. 2002;21:271–81.CrossRefPubMedGoogle Scholar
  25. 25.
    Van Muylem A, Melot C, Antoine M, Knoop C, Estenne M. Role of pulmonary function in the detection of allograft dysfunction after heart-lung transplantation. Thorax. 1997;52:643–7.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Becker FS, Martinez FJ, Brunsting LA, Deeb GM, Flint A, Lynch JP III. Limitations of spirometry in detecting rejection after single-lung transplantation. Am J Respir Crit Care Med. 1994;150:159–66.CrossRefPubMedGoogle Scholar
  27. 27.
    Gotway MB, Dawn SK, Sellami D, Golden JA, Reddy GP, Keith FM, Webb WR. Acute rejection following lung transplantation: limitations in accuracy of thin-section CT for diagnosis. Radiology. 2001;221:207–12.CrossRefPubMedGoogle Scholar
  28. 28.
    Silkoff PE, Caramori M, Tremblay L, McClean P, Chaparro C, Kesten S, Hutcheon M, Slutsky AS, Zamel N, Keshavjee S. Exhaled nitric oxide in human lung transplantation: a noninvasive marker of acute rejection. Am J Respir Crit Care Med. 1998;157:1822–8.CrossRefPubMedGoogle Scholar
  29. 29.
    Gashouta MA, Merlo CA, Pipeling MR, McDyer JF, Hayanga JW, Orens JB, Girgis RE. Serial monitoring of exhaled nitric oxide in lung transplant recipients. J Heart Lung Transplant. 2015;34:557–62.CrossRefPubMedGoogle Scholar
  30. 30.
    De Soyza A, Fisher AJ, Small T, Corris PA. Inhaled corticosteroids and the treatment of lymphocytic bronchiolitis following lung transplantation. Am J Respir Crit Care Med. 2001;164:1209–12.CrossRefPubMedGoogle Scholar
  31. 31.
    Roden AC, Kern RM, Aubry MC, Jenkins SM, Yi ES, Scott JP, Maldonado F. Transbronchial cryobiopsies in the evaluation of lung allografts: do the benefits outweigh the risks? Arch Pathol Lab Med. 2016;140(4):303–11.CrossRefPubMedGoogle Scholar
  32. 32.
    Yarmus L, Akulian J, Gilbert C, Illei P, Shah P, Merlo C, Orens J, Feller-Kopman D. Cryoprobe transbronchial lung biopsy in patients after lung transplantation: a pilot safety study. Chest. 2013;143:621–6.CrossRefPubMedGoogle Scholar
  33. 33.
    Fruchter O, Fridel L, Rosengarten D, Raviv Y, Rosanov V, Kramer MR. Transbronchial cryo-biopsy in lung transplantation patients: first report. Respirology. 2013;18:669–73.CrossRefPubMedGoogle Scholar
  34. 34.
    Stewart S, Fishbein MC, Snell GI, Berry GJ, Boehler A, Burke MM, Glanville A, Gould FK, Magro C, Marboe CC, et al. Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant. 2007;26:1229–42.CrossRefPubMedGoogle Scholar
  35. 35.
    Berry GJ, Brunt EM, Chamberlain D, Hruban RH, Sibley RK, Stewart S, Tazelaar HD. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Lung Rejection Study Group. The International Society for Heart Transplantation. J Heart Transplant. 1990;9:593–601.PubMedGoogle Scholar
  36. 36.
    Yousem SA, Berry GJ, Cagle PT, Chamberlain D, Husain AN, Hruban RH, Marchevsky A, Ohori NP, Ritter J, Stewart S, Tazelaar HD. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group. J Heart Lung Transplant. 1996;15:1–15.PubMedGoogle Scholar
  37. 37.
    Chakinala MM, Ritter J, Gage BF, Aloush AA, Hachem RH, Lynch JP, Patterson GA, Trulock EP. Reliability for grading acute rejection and airway inflammation after lung transplantation. J Heart Lung Transplant. 2005;24:652–7.CrossRefPubMedGoogle Scholar
  38. 38.
    Colombat M, Groussard O, Lautrette A, Thabut G, Marrash-Chahla R, Brugière O, Mal H, Lesèche G, Fournier M, Degott C. Analysis of the different histologic lesions observed in transbronchial biopsy for the diagnosis of acute rejection. Clinicopathologic correlations during the first 6 months after lung transplantation. Hum Pathol. 2005;36:387–94.CrossRefPubMedGoogle Scholar
  39. 39.
    Stephenson A, Flint J, English J, Vedal S, Fradet G, Chittock D, Levy RD. Interpretation of transbronchial lung biopsies from lung transplant recipients: inter- and intraobserver agreement. Can Respir J. 2005;12:75–7.CrossRefPubMedGoogle Scholar
  40. 40.
    Bhorade SM, Husain AN, Liao C, Li LC, Ahya VN, Baz MA, Valentine VG, Love RB, Seethamraju H, Alex CG, et al. Interobserver variability in grading transbronchial lung biopsy specimens after lung transplantation. Chest. 2013;143:1717–24.CrossRefPubMedGoogle Scholar
  41. 41.
    Yousem SA, Martin T, Paradis IL, Keenan R, Griffith BP. Can immunohistological analysis of transbronchial biopsy specimens predict responder status in early acute rejection of lung allografts? Hum Pathol. 1994;25:525–9.CrossRefPubMedGoogle Scholar
  42. 42.
    Reams BD, Musselwhite LW, Zaas DW, Steele MP, Garantziotis S, Eu PC, Snyder LD, Curl J, Lin SS, Davis RD, Palmer SM. Alemtuzumab in the treatment of refractory acute rejection and bronchiolitis obliterans syndrome after human lung transplantation. Am J Transplant. 2007;7:2802–8.CrossRefPubMedGoogle Scholar
  43. 43.
    Trulock EP, Ettinger NA, Brunt EM, Pasque MK, Kaiser LR, Cooper JD. The role of transbronchial lung biopsy in the treatment of lung transplant recipients: an analysis of 200 consecutive procedures. Chest. 1992;102:1049–54.CrossRefPubMedGoogle Scholar
  44. 44.
    Hopkins PM, Aboyoun CL, Chhajed PN, Malouf MA, Plit ML, Rainer SP, Glanville AR. Prospective analysis of 1,235 transbronchial lung biopsies in lung transplant recipients. J Heart Lung Transplant. 2002;21:1062–7.CrossRefPubMedGoogle Scholar
  45. 45.
    Chakinala MM, Ritter J, Gage BF, Lynch JP, Aloush A, Patterson GA, Trulock EP. Yield of surveillance bronchoscopy for acute rejection and lymphocytic bronchitis/bronchiolitis after lung transplantation. J Heart Lung Transplant. 2004;23:1396–404.CrossRefPubMedGoogle Scholar
  46. 46.
    Hopkins PM, Aboyoun CL, Chhajed PN, Malouf MA, Plit ML, Rainer SP, Glanville AR. Association of minimal rejection in lung transplant recipients with obliterative bronchiolitis. Am J Respir Crit Care Med. 2004;170:1022–6.CrossRefPubMedGoogle Scholar
  47. 47.
    Hachem RR, Khalifah AP, Chakinala MM, Yusen RD, Aloush AA, Mohanakumar T, Patterson GA, Trulock EP, Walter MJ. The significance of a single episode of minimal acute rejection after lung transplantation. Transplantation. 2005;80:1406–13.CrossRefPubMedGoogle Scholar
  48. 48.
    Kramer MR, Stoehr C, Whang JL, Berry GJ, Sibley R, Marshall SE, Patterson GM, Starnes VA, Theodore J. The diagnosis of obliterative bronchiolitis after heart-lung and lung transplantation: low yield of transbronchial lung biopsy. J Heart Lung Transplant. 1993;12:675–81.PubMedGoogle Scholar
  49. 49.
    Chamberlain D, Maurer J, Chapparo C, Idolor C. Evaluation of transbronchial biopsy in the diagnosis of bronchiolitis obliterans after lung transplantation. J Heart Lung Transplant. 1994;13:963–71.PubMedGoogle Scholar
  50. 50.
    Pomerance A, Madden B, Burke MM, Yacoub MH. Transbronchial biopsy in heart and lung transplantation: clinicopathologic correlations. J Heart Lung Transplant. 1995;14:761–73.PubMedGoogle Scholar
  51. 51.
    Meyer KC, Raghu G, Verleden GM, Corris PA, Aurora P, Wilson KC, Brozek J, Glanville AR. An international ISHLT/ATS/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome. Eur Respir J. 2014;44:1479–503.CrossRefPubMedGoogle Scholar
  52. 52.
    Saggar R, Ross DJ, Saggar R, Zisman DA, Gregson A, Lynch JP III, Keane MP, Weigt SS, Ardehali A, Kubak B, et al. Pulmonary hypertension associated with lung transplantation obliterative bronchiolitis and vascular remodeling of the allograft. Am J Transplant. 2008;8:1921–30.CrossRefPubMedPubMedCentralGoogle Scholar
  53. 53.
    Nathan SD, Shlobin OA, Ahmad S, Barnett SD, Burton NA, Gladwin MT, Machado RF. Pulmonary hypertension in patients with bronchiolitis obliterans syndrome listed for retransplantation. Am J Transplant. 2008;8:1506–11.CrossRefPubMedGoogle Scholar
  54. 54.
    Tazelaar HD. Perivascular inflammation in pulmonary infections: implications for the diagnosis of lung rejection. J Heart Lung Transplant. 1991;10:437–41.PubMedGoogle Scholar
  55. 55.
    Takemoto SK, Zeevi A, Feng S, Colvin RB, Jordan S, Kobashigawa J, Kupiec-Weglinski J, Matas A, Montgomery RA, Nickerson P, et al. National conference to assess antibody-mediated rejection in solid organ transplantation. Am J Transplant. 2004;4:1033–41.CrossRefPubMedGoogle Scholar
  56. 56.
    Colvin RB, Smith RN. Antibody-mediated organ-allograft rejection. Nat Rev Immunol. 2005;5:807–17.CrossRefPubMedGoogle Scholar
  57. 57.
    Girnita AL, McCurry KR, Iacono AT, Duquesnoy R, Corcoran TE, Awad M, Spichty KJ, Yousem SA, Burckart G, Dauber JH, et al. HLA-specific antibodies are associated with high-grade and persistent-recurrent lung allograft acute rejection. J Heart Lung Transplant. 2004;23:1135–41.CrossRefPubMedGoogle Scholar
  58. 58.
    Palmer SM, Davis RD, Hadjiliadis D, Hertz MI, Howell DN, Ward FE, Savik K, Reinsmoen NL. Development of an antibody specific to major histocompatibility antigens detectable by flow cytometry after lung transplant is associated with bronchiolitis obliterans syndrome. Transplantation. 2002;74:799–804.CrossRefPubMedGoogle Scholar
  59. 59.
    Hadjiliadis D, Chaparro C, Reinsmoen NL, Gutierrez C, Singer LG, Steele MP, Waddell TK, Davis RD, Hutcheon MA, Palmer SM, Keshavjee S. Pre-transplant panel reactive antibody in lung transplant recipients is associated with significantly worse post-transplant survival in a multicenter study. J Heart Lung Transplant. 2005;24:S249–54.CrossRefPubMedGoogle Scholar
  60. 60.
    Appel JZ III, Hartwig MG, Davis RD, Reinsmoen NL. Utility of peritransplant and rescue intravenous immunoglobulin and extracorporeal immunoadsorption in lung transplant recipients sensitized to HLA antigens. Hum Immunol. 2005;66:378–86.CrossRefPubMedGoogle Scholar
  61. 61.
    Jaramillo A, Smith CR, Maruyama T, Zhang L, Patterson GA, Mohanakumar T. Anti-HLA class I antibody binding to airway epithelial cells induces production of fibrogenic growth factors and apoptotic cell death: a possible mechanism for bronchiolitis obliterans syndrome. Hum Immunol. 2003;64:521–9.CrossRefPubMedGoogle Scholar
  62. 62.
    Choi J, Cho YM, Yang WS, Park TJ, Chang JW, Park SK. Peritubular capillary C4d deposition and renal outcome in post-transplant IgA nephropathy. Clin Transpl. 2007;21:159–65.CrossRefGoogle Scholar
  63. 63.
    Herman J, Lerut E, Van Damme-Lombaerts R, Emonds MP, Van Damme B. Capillary deposition of complement C4d and C3d in pediatric renal allograft biopsies. Transplantation. 2005;79:1435–40.CrossRefPubMedGoogle Scholar
  64. 64.
    Moll S, Pascual M. Humoral rejection of organ allografts. Am J Transplant. 2005;5:2611–8.CrossRefPubMedGoogle Scholar
  65. 65.
    Fedson SE, Daniel SS, Husain AN. Immunohistochemistry staining of C4d to diagnose antibody-mediated rejection in cardiac transplantation. J Heart Lung Transplant. 2008;27:372–9.CrossRefPubMedGoogle Scholar
  66. 66.
    Mauiyyedi S, Crespo M, Collins AB, Schneeberger EE, Pascual MA, Saidman SL, Tolkoff-Rubin NE, Williams WW, Delmonico FL, Cosimi AB, Colvin RB. Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification. J Am Soc Nephrol. 2002;13:779–87.PubMedGoogle Scholar
  67. 67.
    Mauiyyedi S, Pelle PD, Saidman S, Collins AB, Pascual M, Tolkoff-Rubin NE, Williams WW, Cosimi AA, Schneeberger EE, Colvin RB. Chronic humoral rejection: identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries. J Am Soc Nephrol. 2001;12:574–82.PubMedGoogle Scholar
  68. 68.
    Rodriguez ER, Skojec DV, Tan CD, Zachary AA, Kasper EK, Conte JV, Baldwin WM III. Antibody-mediated rejection in human cardiac allografts: evaluation of immunoglobulins and complement activation products C4d and C3d as markers. Am J Transplant. 2005;5:2778–85.CrossRefPubMedPubMedCentralGoogle Scholar
  69. 69.
    Smith RN, Brousaides N, Grazette L, Saidman S, Semigran M, Disalvo T, Madsen J, Dec GW, Perez-Atayde AR, Collins AB. C4d deposition in cardiac allografts correlates with alloantibody. J Heart Lung Transplant. 2005;24:1202–10.CrossRefPubMedGoogle Scholar
  70. 70.
    Tan CD, Baldwin WM III, Rodriguez ER. Update on cardiac transplantation pathology. Arch Pathol Lab Med. 2007;131:1169–91.PubMedGoogle Scholar
  71. 71.
    de Kort H, Munivenkatappa RB, Berger SP, Eikmans M, van der Wal A, de Koning EJ, van Kooten C, de Heer E, Barth RN, Bruijn JA, et al. Pancreas allograft biopsies with positive c4d staining and anti-donor antibodies related to worse outcome for patients. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2010;10:1660–7.CrossRefGoogle Scholar
  72. 72.
    Roden AC, Maleszewski JJ, Yi ES, Jenkins SM, Gandhi MJ, Scott JP, Christine Aubry M. Reproducibility of Complement 4d deposition by immunofluorescence and immunohistochemistry in lung allograft biopsies. J Heart Lung Transplant. 2014;33:1223–32.CrossRefPubMedGoogle Scholar
  73. 73.
    Wallace WD, Li N, Andersen CB, Arrossi AV, Askar M, Berry GJ, DeNicola MM, Neil DA, Pavlisko EN, Reed EF, et al. Banff study of pathologic changes in lung allograft biopsy specimens with donor-specific antibodies. J Heart Lung Transplant. 2016;35:40–8.CrossRefPubMedGoogle Scholar
  74. 74.
    Ionescu DN, Girnita AL, Zeevi A, Duquesnoy R, Pilewski J, Johnson B, Studer S, McCurry KR, Yousem SA. C4d deposition in lung allografts is associated with circulating anti-HLA alloantibody. Transpl Immunol. 2005;15:63–8.CrossRefPubMedGoogle Scholar
  75. 75.
    Miller GG, Destarac L, Zeevi A, Girnita A, McCurry K, Iacono A, Murray JJ, Crowe D, Johnson JE, Ninan M, Milstone AP. Acute humoral rejection of human lung allografts and elevation of C4d in bronchoalveolar lavage fluid. Am J Transplant. 2004;4:1323–30.CrossRefPubMedGoogle Scholar
  76. 76.
    Magro CM, Abbas AE, Seilstad K, Pope-Harman AL, Nadasdy T, Ross P Jr. C3d and the septal microvasculature as a predictor of chronic lung allograft dysfunction. Hum Immunol. 2006;67:274–83.CrossRefPubMedGoogle Scholar
  77. 77.
    Westall GP, Snell GI, McLean C, Kotsimbos T, Williams T, Magro C. C3d and C4d deposition early after lung transplantation. J Heart Lung Transplant. 2008;27:722–8.CrossRefPubMedGoogle Scholar
  78. 78.
    Berry G, Burke M, Andersen C, Angelini A, Bruneval P, Calbrese F, Fishbein MC, Goddard M, Leone O, Maleszewski J, et al. Pathology of pulmonary antibody-mediated rejection: 2012 update from the Pathology Council of the ISHLT. J Heart Lung Transplant. 2013;32:14–21.CrossRefPubMedGoogle Scholar
  79. 79.
    Levine DJ, Glanville AR, Aboyoun C, Belperio J, Benden C, Berry GJ, Hachem R, Hayes D, Neil D, Reinsmoen NL, et al. Antibody-mediated rejection of the lung: a consensus report of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2016;35:397–406.CrossRefPubMedGoogle Scholar
  80. 80.
    de Jesus Peixoto Camargo J, Marcantonio Camargo S, Marcelo Schio S, Noguchi Machuca T, Adélia Perin F. Hyperacute rejection after single lung transplantation: a case report. Transplant Proc. 2008;40:867–9.CrossRefPubMedGoogle Scholar
  81. 81.
    Campo-Canaveral de la Cruz JL, Naranjo JM, Salas C, Varela de Ugarte A. Fulminant hyperacute rejection after unilateral lung transplantation. Eur J Cardiothorac Surg. 2012;42:373–5.CrossRefPubMedGoogle Scholar
  82. 82.
    Choi JK, Kearns J, Palevsky HI, Montone KT, Kaiser LR, Zmijewski CM, Tomaszewski JE. Hyperacute rejection of a pulmonary allograft. Immediate clinical and pathologic findings. Am J Respir Crit Care Med. 1999;160:1015–8.CrossRefPubMedGoogle Scholar
  83. 83.
    Scornik JC, Zander DS, Baz MA, Donnelly WH, Staples ED. Susceptibility of lung transplants to preformed donor-specific HLA antibodies as detected by flow cytometry. Transplantation. 1999;68:1542–6.CrossRefPubMedGoogle Scholar
  84. 84.
    Frost AE, Jammal CT, Cagle PT. Hyperacute rejection following lung transplantation. Chest. 1996;110:559–62.CrossRefPubMedGoogle Scholar
  85. 85.
    Masson E, Stern M, Chabod J, Thevenin C, Gonin F, Rebibou JM, Tiberghien P. Hyperacute rejection after lung transplantation caused by undetected low-titer anti-HLA antibodies. J Heart Lung Transplant. 2007;26:642–5.CrossRefPubMedGoogle Scholar
  86. 86.
    Bittner HB, Dunitz J, Hertz M, Bolman MR III, Park SJ. Hyperacute rejection in single lung transplantation—case report of successful management by means of plasmapheresis and antithymocyte globulin treatment. Transplantation. 2001;71:649–51.CrossRefPubMedGoogle Scholar
  87. 87.
    Dawson KL, Parulekar A, Seethamraju H. Treatment of hyperacute antibody-mediated lung allograft rejection with eculizumab. J Heart Lung Transplant. 2012;31:1325–6.CrossRefPubMedGoogle Scholar
  88. 88.
    Scott J, Fradet G, Smyth R, et al. Prospective study of transbronchial biopsies in the management of heart-lung and single lung transplant patients. J Heart Lung Transplant. 1991;10:626–37.PubMedGoogle Scholar
  89. 89.
    Troxell ML, Lanciault C. Practical applications in immunohistochemistry: evaluation of rejection and infection in organ transplantation. Arch Pathol Lab Med. 2016;140(9):910–25.CrossRefPubMedGoogle Scholar

Copyright information

© The Author(s) 2018

Authors and Affiliations

  1. 1.Department of Laboratory Medicine and PathologyMayo Clinic RochesterRochesterUSA
  2. 2.Department of Laboratory Medicine and PathologyMayo Clinic ArizonaScottsdaleUSA

Personalised recommendations